Federal award
QUVA PHARMA, INC.
W81K0019P0334
Contract
Obligated and Ceiling
- Obligated (net)
- $442,635.43
- Ceiling (potential value, not spending)
- $545,078.03
- Current value
- $442,636.43
- Gross positive obligations
- $919,931.76
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- QUVA PHARMA, INC. · MUABDCZXMLG4
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- QUVA PHARMA INC. · JQ6CE5DV8FZ8
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- PIID
- W81K0019P0334
- Award type code
- B
- Actions
- 17 · Sep 6, 2019 to Apr 21, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History17
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Apr 21, 2025 | FY2025 | P00016 | C | −$202,789.43 | — |
| Nov 9, 2023 | FY2024 | P00015 | C | $155,433.60 | — |
| Aug 29, 2023 | FY2023 | P00014 | C | $0.00 | — |
| Jul 12, 2023 | FY2023 | P00013 | G | $0.00 | — |
| Nov 17, 2022 | FY2023 | P00012 | C | $151,100.88 | — |
| Jun 21, 2022 | FY2022 | P00011 | G | $0.00 | — |
| May 18, 2022 | FY2022 | P00010 | M | $0.00 | — |
| Mar 8, 2022 | FY2022 | P00009 | B | $6,862.08 | — |
| Oct 29, 2021 | FY2022 | P00008 | C | $186,411.60 | — |
| Sep 14, 2021 | FY2021 | P00007 | C | −$116,055.29 | — |
| Jul 26, 2021 | FY2021 | P00006 | G | $0.00 | — |
| May 12, 2021 | FY2021 | P00005 | B | −$45,491.61 | — |
| Nov 3, 2020 | FY2021 | P00004 | C | $214,245.60 | — |
| Jul 20, 2020 | FY2020 | P00003 | G | $0.00 | — |
| Jul 10, 2020 | FY2020 | P00002 | C | −$112,960.00 | — |
| Oct 15, 2019 | FY2020 | P00001 | C | $205,878.00 | — |
| Sep 6, 2019 | FY2019 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.